Abstract
Objectives
Artifactually altered glycated hemoglobin (HbA1c) concentrations are frequently linked to hemoglobin (Hb) variants. Their expression and detection require in-depth analysis.
Methods
Cation exchange high performance liquid chromatography (HPLC) (Bio-Rad Variant™ II; Trinity Biotech Premier Hb9210 Resolution), capillary electrophoresis (CE) (Sebia Capillarys 2 Flex Piercing) and mass spectrometry (MS) (Waters) were used for variant detection; Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA) and next generation sequencing (NGS) were used for DNA analysis; HbA1c was measured with cation exchange HPLC (Bio-Rad Variant™ II; Arkray Adams HA-8180V; Tosoh HLC-723 G7), CE (Sebia Capillarys 2 Flex Piercing), boronate affinity HPLC (Trinity Biotech Hb9210 Premier), immunoassay (Cobas c501 Tina-quant HbA1c Gen. 3; Nihon Kohden CHM-4100 Celltac chemi HbA1c HA-411V) and enzymatic assay (Abbott Architect c 8000 HbA1c).
Results
Hb Yamagata [β132(H10)Lys→Asn; (HBB: c.399A>T)] was identified in the proband by MS after the observation of an abnormal peak in HPLC and CE. A mosaic expression of this variant was detected by NGS (mutant: 8%; wild type: 92%), after negative results in Sanger sequencing. Hb Yamagata interfered with HbA1c measurements by cation exchange HPLC and CE whereas immuno and enzymatic assay values showed good agreement with boronate affinity HPLC measurement.
Conclusions
A mosaicism of Hb Yamagata was found in a patient with altered HbA1c values. This rare gene variant was detected only by advanced technologies as MS and NGS. The variant interfered with common HbA1c determination methods.
Acknowledgments
We thank Prof. Joanne Traeger-Synodinos for supporting this work.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: Not applicable.
References
1. Goonasekera, HW, Paththinige, CS, Dissanayake, VHW. Population screening for hemoglobinopathies. Annu Rev Genom Hum Genet 2018;19:355–80. https://doi.org/10.1146/annurev-genom-091416-035451.Search in Google Scholar PubMed
2. Allen, KR, Hamilton, AD, Bodansky, HJ, Poon, P. Prevalence of haemoglobin variants in a diabetic population and their effect on glycated haemoglobin measurement. Ann Clin Biochem 1992;29:426–9. https://doi.org/10.1177/000456329202900410.Search in Google Scholar PubMed
3. Sabath, DE. Molecular diagnosis of thalassemias and hemoglobinopathies: an ACLPS critical review. Am J Clin Pathol 2017;148:6–15. https://doi.org/10.1093/ajcp/aqx047.Search in Google Scholar PubMed
4. Klonoff, DC. Hemoglobinopathies and hemoglobin A1c in diabetes mellitus. J Diabetes Sci Technol 2020;14:3–7. https://doi.org/10.1177/1932296819841698.Search in Google Scholar PubMed PubMed Central
5. Little, RR, Rohlfing, CL, Hanson, S, Connolly, S, Higgins, T, Weykamp, CW, et al.. Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem 2008;54:1277–82. https://doi.org/10.1373/clinchem.2008.103580.Search in Google Scholar PubMed
6. Little, RR, Roberts, WL. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol 2009;3:446–51. https://doi.org/10.1177/193229680900300307.Search in Google Scholar PubMed PubMed Central
7. Lin, CN, Emery, TJ, Little, RR, Hanson, SE, Rohlfing, CL, Jaisson, S, et al.. Effects of hemoglobin C, D, E, and S traits on measurements of HbA1c by six methods. Clin Chim Acta 2012;413:819–21. https://doi.org/10.1016/j.cca.2011.12.019.Search in Google Scholar PubMed PubMed Central
8. Little, RR, Rohlfing, CL, Hanson, SE, Schmidt, RL, Lin, CN, Madsen, RW, et al.. The effect of increased fetal hemoglobin on 7 common Hb A1c assay methods. Clin Chem 2012;58:945–7. https://doi.org/10.1373/clinchem.2012.181933.Search in Google Scholar PubMed PubMed Central
9. Strickland, SW, Campbell, ST, Little, RR, Bruns, DE, Bazydlo, LAL. Recognition of rare hemoglobin variants by hemoglobin A1c measurement procedures. Clin Chim Acta 2018;476:67–74. https://doi.org/10.1016/j.cca.2017.11.012.Search in Google Scholar PubMed
10. Strickland, SW, Campbell, ST, Little, RR, Bruns, DE, Bazydlo, LAL. Prevalence of rare hemoglobin variants identified during measurements of Hb A1c by capillary electrophoresis. Clin Chem 2017;63:1901–2. https://doi.org/10.1373/clinchem.2017.276857.Search in Google Scholar PubMed
11. Traeger-Synodinos, J, Harteveld, CL, Old, JM, Petrou, M, Galanello, R, Giordano, P, et al.. EMQN haemoglobinopathies best practice meeting. EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. Eur J Hum Genet 2015;23:426–37. https://doi.org/10.1038/ejhg.2014.131.Search in Google Scholar
12. Harteveld, CL. State of the art and new developments in molecular diagnostics for hemoglobinopathies in multiethnic societies. Int J Lab Hematol 2014;36:1–12. https://doi.org/10.1111/ijlh.12108.Search in Google Scholar
13. Traeger-Synodinos, J, Harteveld, CL. Advances in technologies for screening and diagnosis of hemoglobinopathies. Biomarkers Med 2014;8:119–31. https://doi.org/10.2217/bmm.13.103.Search in Google Scholar
14. Gajecka, M. Unrevealed mosaicism in the next-generation sequencing era. Mol Genet Genom 2016;291:513–30. https://doi.org/10.1007/s00438-015-1130-7.Search in Google Scholar
15. Wada, Y, Hayashi, A, Masanori, F, Katakuse, I, Ichihara, T, Nakabushi, H, et al.. Characterization of a new fetal hemoglobin variant, Hb F Izumi A gamma 6Glu replaced by Gly, by molecular secondary ion mass spectrometry. Biochim Biophys Acta 1983;749:244–8. https://doi.org/10.1016/0167-4838(83)90231-5.Search in Google Scholar
16. Pucci, P, Carestia, C, Fioretti, G, Mastrobuoni, AM, Pagano, L. Protein fingerprint by fast atom bombardment mass spectrometry: characterization of normal and variant human haemoglobins. Biochem Biophys Res Commun 1985;130:84–90. https://doi.org/10.1016/0006-291x(85)90385-7.Search in Google Scholar
17. Théberge, R, Dikler, S, Heckendorf, C, Chui, DH, Costello, CE, McComb, ME. MALDI-ISD mass spectrometry analysis of hemoglobin variants: a top-down approach to the characterization of hemoglobinopathies. J Am Soc Mass Spectrom 2015;26:1299–310. https://doi.org/10.1007/s13361-015-1164-4.Search in Google Scholar PubMed PubMed Central
18. Bisconte, MG, Caldora, M, Musollino, G, Cardiero, G, Flagiello, A, La Porta, G, et al.. α-Thalassemia associated with Hb instability: a tale of two features. The case of Hb Rogliano or α1 Cod 108(G15)Thr→Asn and Hb Policoro or α2 Cod 124(H7)Ser→Pro. PLoS One 2015;10:e0115738. https://doi.org/10.1371/journal.pone.0115738.Search in Google Scholar PubMed PubMed Central
19. Casale, M, Cozzolino, F, Scianguetta, S, Pucci, P, Monaco, V, Sanchez, G, et al.. Hb vanvitelli: a new unstable alpha-globin chain variant causes undiagnosed chronic haemolytic anaemia when co-inherited with deletion - α3.7. Clin Biochem 2019;74:80–5. https://doi.org/10.1016/j.clinbiochem.2019.09.002.Search in Google Scholar PubMed
20. Saiki, RK, Gelfand, DH, Stoffel, S, Scharf, SJ, Higuchi, R, Horn, GT, et al.. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487–91. https://doi.org/10.1126/science.239.4839.487.Search in Google Scholar
21. Dodé, C, Rochette, J, Krishnamoorthy, R. Locus assignment of human alpha globin mutations by selective amplification and direct sequencing. Br J Haematol 1990;76:275–81. https://doi.org/10.1111/j.1365-2141.1990.tb07884.x.Search in Google Scholar PubMed
22. Lichtman, MA, Murphy, MS, Adamson, JW. Detection of mutant hemoglobins with altered affinity for oxygen. A simplified technique. Ann Intern Med 1976;84:517–20. https://doi.org/10.7326/0003-4819-84-5-517.Search in Google Scholar PubMed
23. National Glycohemoglobin Standardization Program. College of American pathologists (CAP) GH-5b 2020 survey data. Available at: www.ngsp.org [Accessed Nov 2020].Search in Google Scholar
24. Han, JY, Wee, JH, Kim, JM, Kim, JY, Kim, IH, Rodgers, GP. A new observation of Hb Yamagata with a different nucleotide substitution: beta 132 AAA→AAT. Hemoglobin 1996;20:165–8. https://doi.org/10.3109/03630269609027924.Search in Google Scholar PubMed
25. Harano, T, Harano, K, Ueda, S, Imai, K, Marubashi, S. Hb Yamagata [beta 132 (H10) Lys→Asn]: a new abnormal hemoglobin in a Japanese family. Hemoglobin 1990;14:207–11. https://doi.org/10.3109/03630269009046962.Search in Google Scholar PubMed
26. Jung, CL, Kwon, KJ, Hong, KS, Sung, YA, Lee, ST, Ki, CS, et al.. Hemoglobin Yamagata: hemoglobin variant detected by HbA1c test. Korean J Lab Med 2009;29:536–40. https://doi.org/10.3343/kjlm.2009.29.6.536.Search in Google Scholar PubMed
27. Ringelhann, B, Konotey-Ahulu, FI, Talapatra, NC, Nkrumah, FK, Wiltshire, BG, Lehmann, H. Haemoglobin K Woolwich (alpha 2, beta 2 132 lysine leads to glutamine) in Ghana. Acta Haematol 1971;45:250–8. https://doi.org/10.1159/000208632.Search in Google Scholar PubMed
28. Hutt, PJ, Fairbanks, VF, Griffin, TC, Thibodeau, SN, Green, MM, Hoyer, JD. Hb Cook [beta 132(H10)Lys→Thr]: a new hemoglobin variant in a southeast Asian family. Hemoglobin 1996;20:371–6. https://doi.org/10.3109/03630269609005841.Search in Google Scholar PubMed
29. Rodriguez Romero, WE, Castillo, M, Chaves, MA, Saenz, GF, Gu, LH, Wilson, JB, et al.. Hb Costa Rica or alpha 2 beta 2 77(EF1) His→Arg: the first example of a somatic cell mutation in a globin gene. Hum Genet 1996;97:829–33. https://doi.org/10.1007/bf02346198.Search in Google Scholar
30. Schiemsky, T, Van Hoovels, L, Desmet, KJ, Phylipsen, M, Harteveld, CL, Kieffer, DM. A mosaic expression of a Hb J-amiens (HBB: c.54G > T; p.Lys18Asn) and its interference with Hb A1c analysis. Hemoglobin 2015;39:435–7. https://doi.org/10.3109/03630269.2015.1079218.Search in Google Scholar PubMed
31. Wajcman, H, Girodon, E, Promé, D, North, ML, Plassa, F, Duwig, I, et al.. Germline mosaicism for an alanine to valine substitution at residue beta 140 in hemoglobin Puttelange, a new variant with high oxygen affinity. Hum Genet 1995;96:711–6. https://doi.org/10.1007/bf00210304.Search in Google Scholar PubMed
32. Bradley, TB, Wohl, RC, Petz, LD, Perkins, HA, Reynolds, RD. Possible gonadal mosaicism in a family with hemoglobin Köln. Johns Hopkins Med J 1980;146:236–40.Search in Google Scholar
33. Traeger-Synodinos, J, Bosch, CAJ, Vrettou, C, Maragoudaki, L, Apostolidis, J, Kanavakis, E, et al.. Adult-onset beta-thalassaemia intermedia caused by a 5-Mb somatic clonal segmental deletion in haemopoietic stem cells involving the β-globin locus. Br J Haematol 2019;186:e165–70. https://doi.org/10.1111/bjh.16043.Search in Google Scholar PubMed
34. Xu, LL, Liu, YN, Zhen, L, Li, DZ. Germline mosaicism in an alpha-thalassemia family: incidental identification by prenatal ultrasound. Prenat Diagn 2019;39:1166–69. https://doi.org/10.1002/pd.5534.Search in Google Scholar PubMed
35. Smetanina, NS, Gu, LH, Rodriguez Romero, WE, Howard, EF, Huisman, TH. The relative levels of different types of beta-mRNA and beta-globin in BFU-E derived colonies from patients with beta chain variants; further evidence for somatic mosaicism in the Hb Costa Rica carrier [beta 77(EF1)His→Arg]. Hemoglobin 1996;20:199–212. https://doi.org/10.3109/03630269609027929.Search in Google Scholar PubMed
36. Aretz, S, Stienen, D, Friedrichs, N, Stemmler, S, Uhlhaas, S, Rahner, N, et al.. Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Hum Mutat 2007;28:985–92. https://doi.org/10.1002/humu.20549.Search in Google Scholar PubMed
37. Hes, FJ, Nielsen, M, Bik, EC, Konvalinka, D, Wijnen, JT, Bakker, E, et al.. Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut 2008;57:71–6. https://doi.org/10.1136/gut.2006.117796.Search in Google Scholar PubMed
38. Rohlin, A, Wernersson, J, Engwall, Y, Wiklund, L, Björk, J, Nordling, M. Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques. Hum Mutat 2009;30:1012–20. https://doi.org/10.1002/humu.20980.Search in Google Scholar PubMed
39. He, J, Song, W, Yang, J, Lu, S, Yuan, Y, Guo, J, et al.. Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality. China Genet Med 2017;19:1022–31. https://doi.org/10.1038/gim.2016.218.Search in Google Scholar PubMed
40. Shang, X, Peng, Z, Ye, Y, Asan, Zhang, X, Chen, Y, et al.. Rapid targeted next-generation sequencing platform for molecular screening and clinical genotyping in subjects with hemoglobinopathies. EBioMedicine 2017;23:150–9. https://doi.org/10.1016/j.ebiom.2017.08.015.Search in Google Scholar PubMed PubMed Central
41. Pu, J, Zhang, L, Wei, X, Xu, X. Clinical genotyping by next generation sequencing reveals a novel, de novo beta-globin gene mutation causing hemolytic anemia in a Chinese individual. Hemoglobin 2018;42:184–8. https://doi.org/10.1080/03630269.2018.1496928.Search in Google Scholar PubMed
42. Hooven, TA, Hooper, EM, Wontakal, SN, Francis, RO, Sahni, R, Lee, MT. Diagnosis of a rare fetal haemoglobinopathy in the age of next-generation sequencing. BMJ Case Rep 2016;2016:bcr2016215193. https://doi.org/10.1136/bcr-2016-215193.Search in Google Scholar PubMed PubMed Central
43. Yun, YM, Ji, M, Ko, DH, Chun, S, Kwon, GC, Lee, K, et al.. Hb variants in Korea: effect on HbA1c using five routine methods. Clin Chem Lab Med 2017;55:1234–42. https://doi.org/10.1515/cclm-2016-0865.Search in Google Scholar PubMed
44. Little, RR, Vesper, H, Rohlfing, CL, Ospina, M, Safar-Pour, S, Roberts, WL. Validation by a mass spectrometric reference method of use of boronate affinity chromatography to measure glycohemoglobin in the presence of hemoglobin S and C traits. Clin Chem 2005;51:264–5. https://doi.org/10.1373/clinchem.2004.043141.Search in Google Scholar PubMed
45. Little, RR, La’ulu, SL, Hanson, SE, Rohlfing, CL, Schmidt, RL. Effects of 49 different rare Hb variants on HbA1c measurement in eight methods. J Diabetes Sci Technol 2015;9:849–56. https://doi.org/10.1177/1932296815572367.Search in Google Scholar PubMed PubMed Central
46. Rohlfing, C, Connolly, S, Hanson, S, Higgins, T, Little, RR. Validation of the use of trinity biotech ultra2 as a comparative method for hemoglobin A1c measurements in the presence of HbE and HbD-Punjab traits. Clin Chem 2017;63:608–10. https://doi.org/10.1373/clinchem.2016.266221.Search in Google Scholar PubMed
© 2021 Walter de Gruyter GmbH, Berlin/Boston
